Cover Image
市場調查報告書

印度的醫藥品原料藥(API)市場

Active Pharmaceutical Ingredients (API) Market in India 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 323009
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
印度的醫藥品原料藥(API)市場 Active Pharmaceutical Ingredients (API) Market in India 2015-2019
出版日期: 2015年01月14日 內容資訊: 英文 64 Pages
簡介

醫藥品原料藥(API),是用於醫藥品的製造的有藥理效果的活性物質。印度的API市場,從2014年到2019年之間,預計以10.76%的年複合成長率(CAGR)擴大。

本報告提供印度的醫藥品原料藥(API)市場現狀及今後的成長預測調查、各製造工程及各治療領域的市場規模與其預測、市場成長因素與課題、主要企業簡介等資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要

第7章 印度的API市場

  • 市場規模與預測
  • 出口和國內消費
  • 波特的五力分析

第8章 各製造工程類型的市場區隔

第9章 各治療領域的市場區隔

  • 抗感染疾病
  • 心血管及造血系
  • 中樞神經系統
  • 腸胃及肝膽道系
  • 呼吸系統
  • 腫瘤

第10章 購買標準

第11章 市場成長因素

第12章 成長因素與其影響

第13章 市場課題

第14章 成長因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 業者情勢

  • 競爭模式
    • 主要消息
  • 主要供應商排行榜
  • 其他卓越供應商

第18章 主要供應商分析

  • Aurobindo Pharma
  • Cipla
  • Dr. Reddy's Laboratories

第19章 相關報告

目錄
Product Code: IRTNTR5188

About Active Pharmaceutical Ingredients

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.

TechNavio's analysts forecast the API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the API market in India during the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process and area of therapy.

In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the API Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Vendors

  • Aurobindo Pharma
  • Cipla
  • Dr. Reddy's Laboratories

Other Prominent Vendors

  • Anuh Pharma
  • Alembic Pharmaceuticals
  • A. R. Life Sciences
  • Atul Bioscience
  • Biocon
  • Cadila Pharmaceuticals
  • Calyx Chemicals & Pharmaceuticals
  • CIRON Drugs and Pharmaceuticals
  • CTX Life Sciences
  • Dishman Pharmaceuticals & Chemicals
  • Elder Pharmaceuticals
  • Emcure Pharmaceuticals
  • FDC
  • Glenmark Pharmaceuticals
  • Hetero Drugs
  • Hikal
  • Ind-Swift Laboratories
  • Ipca Laboratories
  • J. B. Chemicals and Pharmaceuticals
  • Laurus Labs
  • Lupin
  • Mangalam Drugs & Organics
  • Mylan Laboratories
  • Orchid Chemicals and Pharmaceuticals
  • Ranbaxy Laboratories
  • Sandoz
  • Sequent Scientific
  • Shasun Pharmaceuticals
  • Sterling Biotech
  • Sun Pharmaceutical Industries
  • The Piramal Group
  • Torrent Pharmaceuticals
  • Unichem Laboratories
  • Wockhardt

Market Driver

  • Strong Preference for Generic Drugs
  • For a full, detailed list, view our report

Market Challenge

  • Regulatory Ban
  • For a full, detailed list, view our report

Market Trend

  • Emergence of Africa
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview

07. API Market in India

  • 07.1. Market Size and Forecast
  • 07.2. Export and Domestic Consumption
  • 07.3. Five Forces Analysis

08. Market Segmentation by Type of Production Process

09. Market Segmentation by Area of Therapy

  • 09.1. API Market in India for Anti-infectives
    • 09.1.1. Market Segmentation by Type
  • 09.2. API Market in India for the Cardiovascular and Hematopoietic System
    • 09.2.1. Market Segmentation by Type
  • 09.3. API Market in India for the Central Nervous System
    • 09.3.1. Market Segmentation by Type
  • 09.4. API Market in India for the Gastro-intestinal and Hepatobiliary System
    • 09.4.1. Market Segmentation by Type
  • 09.5. API Market in India for the Respiratory System
    • 09.5.1. Market Segmentation by Type
  • 09.6. API Market in India for Oncology
    • 09.6.1. Market Segmentation by Type

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
  • 17.2. Key Vendor Ranking 2014
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Aurobindo Pharma
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation
    • 18.1.4. Geographical Segmentation by Revenue 2014
    • 18.1.5. Business Strategy
    • 18.1.6. Recent Developments
    • 18.1.7. SWOT Analysis
  • 18.2. Cipla
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Product Segmentation
    • 18.2.4. Geographical Segmentation by Revenue 2014
    • 18.2.5. Business Strategy
    • 18.2.6. Recent Developments
    • 18.2.7. SWOT Analysis
  • 18.3. Dr. Reddy's Laboratories
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2014
    • 18.3.4. Business Segmentation by Revenue 2013 and 2014
    • 18.3.5. Geographical Segmentation by Revenue 2014
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: API Market in India: Segmentation
  • Exhibit 3: API Market in India: Segmentation by Type of Production Process
  • Exhibit 4: API Market in India: Segmentation by Area of Therapy
  • Exhibit 6: API Market in India 2014-2019 (US$ billion)
  • Exhibit 7: API Market in India: Export and Domestic Consumption 2014
  • Exhibit 8: API Market in India: Market Segmentation by Type of Production Process 2014
  • Exhibit 9: API Market in India: Segmentation by Area of Therapy 2014
  • Exhibit 10: API Market in India for Anti-infectives: Segmentation by Type 2014
  • Exhibit 11: API Market in India for the Cardiovascular and Hematopoietic System: Segmentation by Type 2014
  • Exhibit 12: API Market in India for the Central Nervous System: Segmentation by Type 2014
  • Exhibit 13: API Market in India for the Gastro-intestinal and Hepatobiliary System: Segmentation by Type 2014
  • Exhibit 14: API Market in India for the Respiratory System: Segmentation by Type 2014
  • Exhibit 15: API Market in India for Oncology: Segmentation by Type 2014
  • Exhibit 16: Small Molecule Drugs: Patent Expiries 2013-2016
  • Exhibit 17: WHO's List of Prequalified API for Vendors in India (22nd October, 2014)
  • Exhibit 18: Biologic Drugs: Patent Expiries 2014-2019 (EU and US)
  • Exhibit 19: API Market in India: Segmentation by Type of Vendors 2014
  • Exhibit 20: Aurobindo Pharma: Business Segmentation
  • Exhibit 21: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
  • Exhibit 22: Cipla: Product Segmentation
  • Exhibit 23: Cipla: Geographical Segmentation by Revenue 2014
  • Exhibit 24: Active Pharmaceutical Ingredients (API) Market in India: Business Segmentation by Revenue 2014
  • Exhibit 25: Active Pharmaceutical Ingredients (API) Market in India: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
  • Exhibit 26: Dr. Reddy's Laboratories: Geographical Segmentation by Revenue 2014
Back to Top